NKTR
NEKTAR THERAPEUTICS
Company overview
- Market capitalization
- $2.06B
- Employees
- 63
- Latest publication
- 2026-09-29
About NEKTAR THERAPEUTICS
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q2 20182018-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 10,131,000USD | 10,861,000USD | 21,807,000USD | 11,790,000USD | 11,175,000USD | 10,460,000USD | 29,175,000USD | 1,087,717,000USD |
| Cost Of Revenue | -6,517,000USD | 151,000USD | 0USD | 196,000USD | 214,000USD | 426,000USD | 7,977,000USD | 5,522,000USD |
| Gross Profit | 16,648,000USD | 10,710,000USD | 21,807,000USD | 11,594,000USD | 11,175,000USD | 10,460,000USD | 21,198,000USD | 1,082,195,000USD |
| Research Development | 39,129,000USD | 35,680,000USD | 29,712,000USD | 27,252,000USD | 29,886,000USD | 30,480,000USD | 28,745,000USD | 88,334,000USD |
| Selling General Administrative | 12,765,000USD | 13,439,000USD | 11,381,000USD | 15,874,000USD | 17,072,000USD | 24,346,000USD | 17,135,000USD | 20,261,000USD |
| General And Administrative Expenses | 12,765,000USD | — | — | — | — | — | — | — |
| Other Operating Expenses | 7,095,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 58,989,000USD | 48,968,000USD | 40,897,000USD | 43,126,000USD | 47,405,000USD | 54,995,000USD | 6,850,000USD | 108,595,000USD |
| Operating Income | -42,341,000USD | -38,258,000USD | -19,090,000USD | -31,532,000USD | -36,230,000USD | -44,535,000USD | 14,348,000USD | 973,600,000USD |
| Total Other Income Expense Net | 2,040,000USD | -6,582,000USD | -16,958,000USD | -4,023,000USD | -5,551,000USD | -6,295,000USD | -7,346,000USD | 1,745,000USD |
| Interest Income | 9,346,000USD | 4,242,000USD | 2,776,000USD | 2,819,000USD | 1,969,000USD | 2,874,000USD | 2,942,000USD | — |
| Income Before Tax | -40,301,000USD | -44,840,000USD | -36,048,000USD | -35,555,000USD | -41,781,000USD | -50,830,000USD | 7,002,000USD | 975,345,000USD |
| Income Tax Expense | 2,000USD | 64,000USD | 31,000USD | -33,000USD | -188,000USD | 52,000USD | -259,000USD | 3,885,000USD |
| Equity Method Income Loss | -319,000USD | — | — | — | — | — | — | — |
| Net Income | -40,622,000USD | -44,904,000USD | -36,079,000USD | -35,522,000USD | -41,593,000USD | -50,882,000USD | 7,261,000USD | 971,460,000USD |
| Selling And Marketing Expenses | — | -151,000USD | — | — | — | — | — | — |
| Interest Expense | — | 7,942,000USD | 9,769,000USD | 6,047,000USD | 5,394,000USD | 4,974,000USD | 10,153,000USD | 10,360,000USD |
| Net Interest Income | — | -3,700,000USD | -6,993,000USD | -3,228,000USD | -3,425,000USD | -2,100,000USD | -7,211,000USD | — |
| Tax Provision | — | 64,000USD | 31,000USD | -33,000USD | -188,000USD | 52,000USD | -259,000USD | — |
| Net Income From Continuing Ops | — | -44,904,000USD | -36,079,000USD | -35,522,000USD | -41,593,000USD | -50,882,000USD | 7,261,000USD | 971,460,000USD |
| Ebit | — | -36,898,000USD | -26,279,000USD | -29,508,000USD | -34,001,000USD | -41,395,000USD | 17,155,000USD | 985,705,000USD |
| Ebitda | — | -36,747,000USD | -26,089,000USD | -29,312,000USD | -33,787,000USD | -40,969,000USD | 17,487,000USD | 988,279,000USD |
| Depreciation And Amortization | — | 151,000USD | 190,000USD | 196,000USD | 214,000USD | 426,000USD | 332,000USD | 2,574,000USD |
| Reconciled Depreciation | — | 151,000USD | 190,000USD | 196,000USD | 214,000USD | 426,000USD | 332,000USD | 2,574,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | -39,030,000USD | — |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 12,105,000USD |
| Minority Interest | — | — | — | — | — | — | — | 0USD |
| Discontinued Operations | — | — | — | — | — | — | — | 0USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | — | 971,460,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20182018-12-31 · USD | FY 19981998-12-31 · USD | FY 19971997-12-31 · USD | FY 19941994-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 55,232,000USD | 1,193,323,000USD | 21,795,000USD | 16,249,000USD | 1,700,000USD |
| Cost Of Revenue | 0USD | 24,412,000USD | — | — | -500,000USD |
| Gross Profit | 55,232,000USD | 1,168,911,000USD | 21,795,000USD | 16,249,000USD | 2,200,000USD |
| Research Development | 117,330,000USD | 399,536,000USD | 35,398,000USD | 23,645,000USD | — |
| Selling General Administrative | 68,673,000USD | 81,443,000USD | 8,387,000USD | 6,328,000USD | — |
| Total Operating Expenses | 186,003,000USD | 480,979,000USD | 43,785,000USD | 29,973,000USD | 7,900,000USD |
| Operating Income | -130,770,999USD | 687,932,000USD | -21,990,000USD | -13,724,000USD | -5,700,000USD |
| Interest Income | 10,438,000USD | 37,571,000USD | — | — | — |
| Interest Expense | 26,184,000USD | 42,778,000USD | 0USD | 0USD | 0USD |
| Net Interest Income | -15,746,000USD | -5,207,000USD | — | — | — |
| Income Before Tax | -164,214,000USD | 682,725,000USD | — | — | -5,100,000USD |
| Income Tax Expense | -138,000USD | 1,412,000USD | -3,634,000USD | -3,741,000USD | -400,000USD |
| Tax Provision | -138,000USD | 1,412,000USD | — | — | — |
| Net Income | -164,076,000USD | 681,313,000USD | -18,356,000USD | -9,983,000USD | -5,300,000USD |
| Net Income From Continuing Ops | -164,076,000USD | 681,313,000USD | — | — | — |
| Ebit | -138,030,000USD | 725,503,000USD | -21,990,000USD | -13,724,000USD | -5,700,000USD |
| Ebitda | -137,004,000USD | 734,303,000USD | -18,392,000USD | -11,286,000USD | -5,200,000USD |
| Depreciation And Amortization | 1,026,000USD | 8,800,000USD | 3,598,000USD | 2,438,000USD | 500,000USD |
| Reconciled Depreciation | 1,026,000USD | 10,870,000USD | — | — | — |
| Total Other Income Expense Net | -33,443,000USD | -5,207,000USD | — | — | 600,000USD |
| Non Operating Income Net Other | — | 37,571,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | 681,313,000USD | — | — | — |
| Other Operating Expenses | — | — | — | — | 7,400,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,095,129,000USD | 763,271,000USD | 280,406,000USD | 301,347,000USD | 207,534,000USD | 256,241,000USD | 303,850,000USD | 307,966,000USD |
| Cash And Equivalents | 39,267,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 739,402,000USD | 589,041,000USD | 266,266,000USD | 281,357,000USD | 186,566,000USD | 229,913,000USD | 261,292,000USD | 286,481,000USD |
| Other Current Assets | 55,061,000USD | 16,837,000USD | 18,735,000USD | 9,860,000USD | 9,312,000USD | 9,567,000USD | 4,457,000USD | 39,863,000USD |
| Other Non Current Assets | 16,666,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 192,008,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 70,985,000USD | 57,708,000USD | 53,536,000USD | 66,340,000USD | 71,391,000USD | 70,930,000USD | 61,400,000USD | 67,583,000USD |
| Other Current Liabilities | 23,388,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 7,795,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 903,121,000USD | 576,216,000USD | 89,832,000USD | 85,086,000USD | -24,211,000USD | 13,738,000USD | 60,737,000USD | 48,884,000USD |
| Total Equity Including Noncontrolling Interest | 903,121,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 24,891,000USD | 10,026,000USD | 10,770,000USD | 15,563,000USD | 14,281,000USD | 17,834,000USD | 11,560,000USD | 8,577,000USD |
| Short Term Debt | 22,706,000USD | 22,531,000USD | 20,495,000USD | 22,183,000USD | 22,011,000USD | 21,842,000USD | 19,868,000USD | 21,504,000USD |
| Common Stock | 3,000USD | 3,000USD | 2,000USD | 2,000USD | 1,000USD | 19,000USD | 19,000USD | 19,000USD |
| Retained Earnings | -3,845,812,000USD | -3,805,190,000USD | -3,760,286,000USD | -3,724,207,000USD | -3,688,685,000USD | -3,647,092,000USD | -3,596,210,000USD | -3,603,471,000USD |
| Accumulated Other Comprehensive Income | -1,756,000USD | -1,034,000USD | 17,000USD | 56,000USD | -14,000USD | 39,000USD | 61,000USD | 355,000USD |
| Total Liab | — | 187,055,000USD | 190,574,000USD | 216,261,000USD | 231,745,000USD | 242,503,000USD | 243,113,000USD | 259,082,000USD |
| Other Current Liab | — | 25,151,000USD | 22,271,000USD | 28,594,000USD | 35,099,000USD | 31,254,000USD | 29,972,000USD | 37,502,000USD |
| Capital Stock | — | 3,000USD | 2,000USD | 2,000USD | 1,000USD | 19,000USD | 19,000USD | 19,000USD |
| Other Assets | — | 1USD | — | — | — | — | — | — |
| Cash | — | 131,868,000USD | 15,116,000USD | 41,032,000USD | 42,988,000USD | 38,894,000USD | 44,252,000USD | 30,109,000USD |
| Cash And Short Term Investments | — | 568,604,000USD | 245,752,000USD | 270,208,000USD | 175,903,000USD | 218,632,000USD | 255,226,000USD | 244,495,000USD |
| Net Debt | — | 11,564,000USD | 133,792,000USD | 50,883,000USD | 53,168,000USD | 61,443,000USD | 58,312,000USD | 78,153,000USD |
| Short Long Term Debt Total | — | 143,432,000USD | 148,908,000USD | 91,915,000USD | 96,156,000USD | 100,337,000USD | 102,564,000USD | 108,262,000USD |
| Long Term Investments | — | 162,993,000USD | 3,491,000USD | 4,837,000USD | 5,371,000USD | 9,776,000USD | 26,087,000USD | 4,537,000USD |
| Short Term Investments | — | 436,736,000USD | 230,636,000USD | 229,176,000USD | 132,915,000USD | 179,738,000USD | 210,974,000USD | 214,386,000USD |
| Net Receivables | — | 3,600,000USD | 1,779,000USD | 1,289,000USD | 1,351,000USD | 1,714,000USD | 1,609,000USD | 2,123,000USD |
| Property Plant Equipment Net | — | 4,720,000USD | 5,001,000USD | 9,997,000USD | 10,573,000USD | 11,161,000USD | 11,824,000USD | 12,429,000USD |
| Common Stock Shares Outstanding | — | 24,736,066shares | 20,296,885shares | 14,087,307shares | 14,087,307shares | 14,061,600shares | 14,239,600shares | 13,949,933shares |
| Non Current Assets Total | — | 174,229,999USD | 14,139,999USD | 19,990,000USD | 20,968,000USD | 26,328,000USD | 42,558,000USD | 21,485,000USD |
| Non Current Liabilities Total | — | 129,347,000USD | 137,038,000USD | 149,921,000USD | 160,354,000USD | 171,573,000USD | 181,713,000USD | 191,499,000USD |
| Non Current Liabilities Other | — | 68,716,000USD | 71,782,000USD | 80,189,000USD | 86,209,000USD | 93,078,000USD | 99,017,000USD | 104,741,000USD |
| Non Currrent Assets Other | — | 4,775,999USD | 5,647,999USD | 5,156,000USD | 5,024,000USD | 5,391,000USD | 4,647,000USD | 4,519,000USD |
| Net Working Capital | — | 531,333,000USD | 212,730,000USD | 215,017,000USD | 115,175,000USD | 158,983,000USD | 199,892,000USD | 218,898,000USD |
| Unclassified Non Current Liabilities | — | 60,631,000USD | 65,256,000USD | 69,732,000USD | 74,145,000USD | 78,495,000USD | 82,696,000USD | 86,758,000USD |
| Unclassified Equity | — | 4,382,434,000USD | 3,850,097,000USD | 3,809,233,000USD | 3,664,486,000USD | 3,660,753,000USD | 3,656,848,000USD | 3,651,962,000USD |
| Property Plant Equipment Gross | — | — | 5,001,000USD | 9,997,000USD | 10,573,000USD | 11,161,000USD | 27,734,000USD | 28,088,000USD |
| Inventory | — | — | — | — | — | — | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 280,406,000USD | 303,850,000USD | 398,033,000USD | 710,600,000USD | 1,117,189,000USD | 1,538,767,000USD | 1,977,356,000USD | 2,150,172,000USD |
| Other Current Assets | 18,735,000USD | 4,457,000USD | 8,732,000USD | 13,385,000USD | 23,333,000USD | 21,928,000USD | 47,221,000USD | 21,293,000USD |
| Total Liab | 190,574,000USD | 243,113,000USD | 267,046,000USD | 343,962,000USD | 437,681,000USD | 461,472,000USD | 571,965,000USD | 432,597,000USD |
| Total Stockholder Equity | 89,832,000USD | 60,737,000USD | 130,987,000USD | 366,638,000USD | 679,508,000USD | 1,077,295,000USD | 1,405,391,000USD | 1,717,575,000USD |
| Other Current Liab | 22,271,000USD | 29,972,000USD | 22,162,000USD | 36,557,000USD | 58,012,000USD | 79,634,000USD | 63,735,000USD | 493,000USD |
| Common Stock | 2,000USD | 19,000USD | 19,000USD | 19,000USD | 19,000USD | 18,000USD | 17,000USD | 17,000USD |
| Capital Stock | 2,000USD | 19,000USD | 19,000USD | 19,000USD | 19,000USD | 18,000USD | 17,000USD | 17,000USD |
| Retained Earnings | -3,760,286,000USD | -3,596,210,000USD | -3,477,249,000USD | -3,201,193,000USD | -2,832,995,000USD | -2,309,158,000USD | -1,864,718,000USD | -1,424,051,000USD |
| Cash | 15,116,000USD | 44,252,000USD | 35,277,000USD | 88,227,000USD | 25,218,000USD | 198,955,000USD | 96,363,000USD | 194,905,000USD |
| Cash And Short Term Investments | 245,752,000USD | 255,226,000USD | 303,616,000USD | 504,977,000USD | 733,955,000USD | 1,061,896,000USD | 1,324,862,000USD | 1,335,350,000USD |
| Total Current Assets | 266,266,000USD | 261,292,000USD | 330,701,000USD | 545,968,000USD | 795,581,000USD | 1,138,005,000USD | 1,421,550,000USD | 1,437,687,000USD |
| Total Current Liabilities | 53,536,000USD | 61,400,000USD | 51,269,000USD | 68,204,000USD | 85,200,000USD | 115,779,000USD | 353,893,000USD | 82,002,000USD |
| Net Debt | 133,792,000USD | 58,312,000USD | 82,499,000USD | 43,269,000USD | 117,959,000USD | -48,667,000USD | 311,774,000USD | 52,045,000USD |
| Short Term Debt | 20,495,000USD | 19,868,000USD | 19,259,000USD | 18,667,000USD | 17,441,000USD | 13,915,000USD | 265,407,000USD | 61,763,000USD |
| Short Long Term Debt Total | 148,908,000USD | 102,564,000USD | 117,776,000USD | 131,496,000USD | 143,177,000USD | 150,288,000USD | 408,137,000USD | 308,713,000USD |
| Long Term Investments | 3,491,000USD | 26,087,000USD | 25,825,000USD | 0USD | 64,828,000USD | 136,662,000USD | 279,119,000USD | 582,889,000USD |
| Short Term Investments | 230,636,000USD | 210,974,000USD | 268,339,000USD | 416,750,000USD | 708,737,000USD | 862,941,000USD | 1,228,499,000USD | 1,140,445,000USD |
| Net Receivables | 1,779,000USD | 1,609,000USD | 2,252,000USD | 8,404,000USD | 22,492,000USD | 38,889,000USD | 36,802,000USD | 43,213,000USD |
| Accounts Payable | 10,770,000USD | 11,560,000USD | 9,848,000USD | 12,980,000USD | 9,747,000USD | 22,139,000USD | 19,234,000USD | 5,854,000USD |
| Property Plant Equipment Net | 5,001,000USD | 11,824,000USD | 36,863,000USD | 85,886,000USD | 177,535,000USD | 186,138,000USD | 199,842,000USD | 48,851,000USD |
| Property Plant Equipment Gross | 5,001,000USD | 27,734,000USD | 123,761,000USD | 85,886,000USD | 177,535,000USD | 186,138,000USD | 199,176,000USD | 48,851,000USD |
| Accumulated Other Comprehensive Income | 17,000USD | 61,000USD | 80,000USD | -6,907,000USD | -4,157,000USD | -2,295,000USD | -1,005,000USD | -6,316,000USD |
| Common Stock Shares Outstanding | 16,870,930shares | 13,710,733shares | 12,666,733shares | 12,475,867shares | 12,219,866shares | 11,905,400shares | 11,666,200shares | 12,007,933shares |
| Non Current Assets Total | 14,140,000USD | 42,558,000USD | 67,332,000USD | 164,632,000USD | 321,608,000USD | 400,762,000USD | 555,806,000USD | 712,485,000USD |
| Non Current Liabilities Total | 137,038,000USD | 181,713,000USD | 215,777,000USD | 275,758,000USD | 352,481,000USD | 345,693,000USD | 218,072,000USD | 350,595,000USD |
| Non Current Liabilities Other | 71,782,000USD | 99,017,000USD | 117,260,000USD | 162,929,000USD | 3,592,000USD | 345,693,000USD | 218,072,000USD | 103,645,000USD |
| Non Currrent Assets Other | 5,648,000USD | 4,647,000USD | 4,644,000USD | 2,245,000USD | 2,744,000USD | 1,461,000USD | 344,000USD | 4,244,000USD |
| Net Working Capital | 212,730,000USD | 199,892,000USD | 279,432,000USD | 477,764,000USD | 710,381,000USD | 1,022,226,000USD | 1,067,657,000USD | 1,355,685,000USD |
| Unclassified Non Current Liabilities | 65,256,000USD | 82,696,000USD | 98,517,000USD | -50,100,000USD | 122,144,000USD | -209,320,000USD | -75,342,000USD | -103,645,000USD |
| Unclassified Equity | 3,850,097,000USD | 3,656,848,000USD | 3,608,118,000USD | 3,574,700,000USD | 3,516,622,000USD | 3,388,712,000USD | 3,271,080,000USD | 3,147,908,000USD |
| Inventory | — | 0USD | 16,101,000USD | 19,202,000USD | 15,801,000USD | 15,292,000USD | 12,665,000USD | 11,381,000USD |
| Good Will | — | — | 0USD | 76,501,000USD | 76,501,000USD | 76,501,000USD | 76,501,000USD | 76,501,000USD |
| Current Deferred Revenue | — | — | -8,203,000USD | — | — | 91,000USD | 5,517,000USD | 13,892,000USD |
| Other Liab | — | — | — | 162,929,000USD | 226,745,000USD | 209,320,000USD | 75,342,000USD | 103,645,000USD |
| Other Assets | — | — | — | 2,245,000USD | 2,744,000USD | 264,599,000USD | 1,010,000USD | 4,244,000USD |
| Net Tangible Assets | — | — | — | 290,137,000USD | 603,007,000USD | 1,000,794,000USD | 1,328,890,000USD | 1,641,074,000USD |
| Unclassified Non Current Assets | — | — | — | -2,245,000USD | — | -264,599,000USD | -27,920,000USD | — |
| Intangible Assets | — | — | — | — | — | — | 26,910,000USD | — |
| Short Long Term Debt | — | — | — | — | — | — | 248,693,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | — | — | -248,693,000USD | — |
| Long Term Debt | — | — | — | — | — | — | — | 246,950,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | 26,450,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 307,000USD |
| Change To Liabilities | 14,121,000USD |
| Change In Working Capital | -25,763,000USD |
| Operating Cash Flow | -120,068,000USD |
| Capital Expenditures | -112,000USD |
| Net Investments | -749,787,000USD |
| Investing Cash Flow | -749,899,000USD |
| Financing Cash Flow | 894,118,000USD |
| Effect Of Forex Changes On Cash | 0USD |
| Change In Cash | 24,151,000USD |
| End Cash Flow | 39,267,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -44,904,000USD | -36,079,000USD | -35,522,000USD | -41,593,000USD | -50,882,000USD | 7,261,000USD | -37,057,000USD | -52,363,000USD |
| Depreciation | 151,000USD | -374,000USD | 196,000USD | -655,000USD | 426,000USD | 332,000USD | 993,000USD | 1,459,000USD |
| Stock Based Compensation | 3,355,000USD | 2,193,000USD | 3,072,000USD | 3,486,000USD | 3,898,000USD | 4,803,000USD | 5,391,000USD | 5,418,000USD |
| Other Non Cash Items | -2,832,000USD | -7,575,000USD | -6,342,000USD | -3,395,000USD | -2,349,000USD | -47,068,000USD | -14,291,000USD | -3,076,000USD |
| Change In Working Capital | -68,000USD | -23,124,000USD | -10,165,000USD | -3,581,000USD | -146,000USD | -11,515,000USD | 1,063,000USD | 10,803,000USD |
| Total Cash From Operating Activities | -44,298,000USD | -64,959,000USD | -48,761,000USD | -45,738,000USD | -49,053,000USD | -46,187,000USD | -43,932,000USD | -37,702,000USD |
| Capital Expenditures | -18,000USD | -18,000USD | -114,000USD | -37,000USD | -2,000USD | -459,000USD | -666,000USD | -186,000USD |
| Free Cash Flow | -44,316,000USD | -64,977,000USD | -48,875,000USD | -45,775,000USD | -49,055,000USD | -46,646,000USD | -44,598,000USD | -37,888,000USD |
| Investments | -350,771,000USD | 390,000USD | -94,873,000USD | 49,615,000USD | 43,689,000USD | 60,214,000USD | 46,116,000USD | 16,982,000USD |
| Total Cashflows From Investing Activities | -350,789,000USD | 372,000USD | -94,873,000USD | 49,615,000USD | 43,689,000USD | 60,214,000USD | 46,116,000USD | 16,982,000USD |
| Total Cash From Financing Activities | 529,549,000USD | 38,671,000USD | 141,677,000USD | 211,000USD | 7,000USD | 83,000USD | 13,000USD | 19,000USD |
| Issuance Of Capital Stock | 525,519,000USD | 38,261,000USD | — | — | 0USD | — | — | — |
| Change In Cash | 128,671,000USD | -1,199,000USD | -1,956,000USD | 4,094,000USD | -5,358,000USD | 14,143,000USD | 2,142,999USD | -20,824,000USD |
| Begin Period Cash Flow | 3,197,000USD | 16,315,000USD | 42,988,000USD | 38,894,000USD | 44,252,000USD | 30,109,000USD | 13,920,000USD | 34,744,000USD |
| End Period Cash Flow | 131,868,000USD | 15,116,000USD | 41,032,000USD | 42,988,000USD | 38,894,000USD | 44,252,000USD | 16,062,999USD | 13,920,000USD |
| Change To Account Receivables | — | 0USD | 0USD | 0USD | 0USD | -2,204,000USD | -850,000USD | 2,421,000USD |
| Change To Inventory | — | 0USD | 0USD | 0USD | 0USD | 1,305,000USD | 123,000USD | 212,000USD |
| Sale Purchase Of Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Other Cashflows From Financing Activities | — | 38,671,000USD | -912,000USD | — | 7,000USD | 83,000USD | 13,000USD | 19,000USD |
| Unclassified Financing Cash Flow | — | — | 142,589,000USD | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | -697,000USD | 65,386,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | -64,927,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -164,076,000USD | -118,961,000USD | -276,056,000USD | -368,198,000USD | -523,837,000USD | -444,440,000USD | -440,667,000USD | 681,313,000USD |
| Depreciation | -4,488,000USD | 4,391,000USD | 7,815,000USD | 13,030,000USD | 14,146,000USD | 14,182,000USD | 13,156,000USD | 10,870,000USD |
| Stock Based Compensation | 12,649,000USD | 21,612,000USD | 33,388,000USD | 57,320,000USD | 94,674,000USD | 94,261,000USD | 99,795,000USD | 88,101,000USD |
| Other Non Cash Items | -15,580,000USD | -76,512,000USD | 62,187,000USD | -9,359,000USD | 17,410,000USD | -14,353,000USD | -22,653,000USD | -23,064,000USD |
| Change To Account Receivables | 0USD | -3,045,000USD | 4,776,000USD | 16,511,000USD | 12,397,000USD | 1,913,000USD | 6,411,000USD | -25,505,000USD |
| Change To Inventory | 0USD | 497,000USD | 699,000USD | -3,401,000USD | -509,000USD | -2,627,000USD | -1,284,000USD | -655,000USD |
| Change In Working Capital | -37,016,000USD | -6,239,000USD | -19,800,000USD | 492,000USD | -23,076,000USD | 16,712,000USD | 21,688,000USD | -39,006,000USD |
| Total Cash From Operating Activities | -208,511,000USD | -175,709,000USD | -192,606,000USD | -304,007,000USD | -412,660,000USD | -313,287,000USD | -328,681,000USD | 718,214,000USD |
| Capital Expenditures | -171,000USD | -1,468,000USD | -865,000USD | -5,676,000USD | -14,989,000USD | -7,258,000USD | -26,285,000USD | -14,239,000USD |
| Free Cash Flow | -208,682,000USD | -177,177,000USD | -193,471,000USD | -309,683,000USD | -427,649,000USD | -320,545,000USD | -354,966,000USD | 703,975,000USD |
| Investments | -329,000USD | 142,570,000USD | 162,195,000USD | 365,835,000USD | 217,766,000USD | 503,471,000USD | 233,171,000USD | -1,368,330,000USD |
| Total Cashflows From Investing Activities | -1,197,000USD | 142,570,000USD | 139,564,000USD | 365,835,000USD | 202,777,000USD | 496,213,000USD | 206,886,000USD | -1,379,936,000USD |
| Total Cash From Financing Activities | 180,566,000USD | 42,118,000USD | 30,000USD | 1,508,000USD | 36,238,000USD | -80,354,000USD | 23,355,000USD | 851,966,000USD |
| Sale Purchase Of Stock | 0USD | -3,000,000USD | 0USD | — | 33,238,000USD | 23,396,000USD | 23,355,000USD | 851,966,000USD |
| Issuance Of Capital Stock | 180,850,000USD | 0USD | — | — | — | 0USD | 0USD | 790,231,000USD |
| Change In Cash | -29,136,000USD | 8,975,000USD | -52,950,000USD | 63,009,000USD | -173,737,000USD | 102,592,000USD | -98,542,000USD | 190,143,000USD |
| Begin Period Cash Flow | 44,252,000USD | 35,277,000USD | 88,227,000USD | 25,218,000USD | 198,955,000USD | 96,363,000USD | 194,905,000USD | 4,762,000USD |
| End Period Cash Flow | 15,116,000USD | 44,252,000USD | 35,277,000USD | 88,227,000USD | 25,218,000USD | 198,955,000USD | 96,363,000USD | 194,905,000USD |
| Other Cashflows From Investing Activities | -697,000USD | 65,386,000USD | 1,245,000USD | 371,511,000USD | 217,766,000USD | 503,471,000USD | 233,171,000USD | 2,633,000USD |
| Other Cashflows From Financing Activities | 180,566,000USD | 15,000,000USD | 30,000USD | 750,000USD | 3,000,000USD | 496,213,000USD | 23,355,000USD | 61,735,000USD |
| Unclassified Investing Cash Flow | — | -63,918,000USD | -23,011,000USD | -365,835,000USD | -217,766,000USD | -503,471,000USD | -233,171,000USD | — |
| Unclassified Financing Cash Flow | — | 30,118,000USD | — | — | — | -349,963,000USD | 226,645,000USD | 188,265,000USD |
| Change To Liabilities | — | — | — | 2,043,000USD | -12,295,000USD | 15,723,000USD | 18,846,000USD | 34,137,000USD |
| Net Borrowings | — | — | — | 0USD | 0USD | -250,000,000USD | -250,000,000USD | -250,000,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | -173,645,000USD | 102,572,000USD | -98,440,000USD | 190,244,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | 8,023,000USD | 20,351,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Geography | International | 55,232,000 | USD | 0001193125-26-104547 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 0 | USD | 0001193125-26-104547 |
| Q3 2025Quarterly · 2025-09-30 | Product | License Collaboration And Other Revenue | 300,000 | USD | 0001193125-25-270230 |
| Q3 2025Quarterly · 2025-09-30 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 11,500,000 | USD | 0001193125-25-270230 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 0 | USD | 0001193125-25-270230 |
| Q2 2025Quarterly · 2025-06-30 | Product | License Collaboration And Other Revenue | 0 | USD | 0000950170-25-105275 |
| Q2 2025Quarterly · 2025-06-30 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 11,200,000 | USD | 0000950170-25-105275 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 0 | USD | 0000950170-25-105275 |
| Q1 2025Quarterly · 2025-03-31 | Product | License Collaboration And Other Revenue | 0 | USD | 0000950170-25-067279 |
| Q1 2025Quarterly · 2025-03-31 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 10,500,000 | USD | 0000950170-25-067279 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 0 | USD | 0000950170-25-067279 |
| FY 2024Yearly · 2024-12-31 | Geography | International | 97,052,000 | USD | 0001193125-26-104547 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 1,375,000 | USD | 0001193125-26-104547 |
| Q3 2024Quarterly · 2024-09-30 | Product | License Collaboration And Other Revenue | 409,000 | USD | 0001193125-25-270230 |
| Q3 2024Quarterly · 2024-09-30 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 15,700,000 | USD | 0001193125-25-270230 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 8,015,000 | USD | 0001193125-25-270230 |
| Q2 2024Quarterly · 2024-06-30 | Product | License Collaboration And Other Revenue | 59,000 | USD | 0000950170-25-105275 |
| Q2 2024Quarterly · 2024-06-30 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 16,800,000 | USD | 0000950170-25-105275 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 6,640,000 | USD | 0000950170-25-105275 |
| Q1 2024Quarterly · 2024-03-31 | Product | License Collaboration And Other Revenue | 97,000 | USD | 0000950170-25-067279 |
| Q1 2024Quarterly · 2024-03-31 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 15,500,000 | USD | 0000950170-25-067279 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product | 6,034,000 | USD | 0000950170-25-067279 |
| FY 2023Yearly · 2023-12-31 | Geography | International | 78,641,000 | USD | 0000950170-25-039389 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 11,481,000 | USD | 0000950170-25-039389 |
| Q3 2023Quarterly · 2023-09-30 | Product | License Collaboration And Other Revenue | 155,000 | USD | 0000950170-24-123570 |
| Q3 2023Quarterly · 2023-09-30 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 18,200,000 | USD | 0000950170-24-123570 |
| Q3 2023Quarterly · 2023-09-30 | Product | Product | 5,822,000 | USD | 0000950170-24-123570 |
| Q2 2023Quarterly · 2023-06-30 | Product | License Collaboration And Other Revenue | 41,000 | USD | 0000950170-24-094231 |
| Q2 2023Quarterly · 2023-06-30 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 15,800,000 | USD | 0000950170-24-094231 |
| Q2 2023Quarterly · 2023-06-30 | Product | Product | 4,658,000 | USD | 0000950170-24-094231 |
| FY 2022Yearly · 2022-12-31 | Geography | International | 82,214,000 | USD | 0000950170-24-026249 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 9,841,000 | USD | 0000950170-24-026249 |
| FY 2021Yearly · 2021-12-31 | Geography | International | 91,793,000 | USD | 0000950170-24-026249 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 10,114,000 | USD | 0000950170-24-026249 |
| FY 2020Yearly · 2020-12-31 | Geography | International | 87,949,000 | USD | 0000906709-23-000004 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 64,966,000 | USD | 0000906709-23-000004 |
| FY 2020Yearly · 2020-12-31 | Product | License Collaboration And Other Revenue | 55,849,000 | USD | 0000906709-21-000005 |
| FY 2020Yearly · 2020-12-31 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 48,563,000 | USD | 0000906709-21-000005 |
| FY 2020Yearly · 2020-12-31 | Product | Product | 17,504,000 | USD | 0000906709-21-000005 |
| FY 2020Yearly · 2020-12-31 | Product | Royalty | 30,999,000 | USD | 0000906709-21-000005 |
| FY 2019Yearly · 2019-12-31 | Geography | International | 87,524,000 | USD | 0000906709-22-000005 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 27,093,000 | USD | 0000906709-22-000005 |
| FY 2019Yearly · 2019-12-31 | Product | License Collaboration And Other Revenue | 16,975,000 | USD | 0000906709-21-000005 |
| FY 2019Yearly · 2019-12-31 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 36,303,000 | USD | 0000906709-21-000005 |
| FY 2019Yearly · 2019-12-31 | Product | Product | 20,117,000 | USD | 0000906709-21-000005 |
| FY 2019Yearly · 2019-12-31 | Product | Royalty | 41,222,000 | USD | 0000906709-21-000005 |
| FY 2018Yearly · 2018-12-31 | Geography | International | 102,529,000 | USD | 0000906709-21-000005 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 1,090,794,000 | USD | 0000906709-21-000005 |
| FY 2018Yearly · 2018-12-31 | Product | License Collaboration And Other Revenue | 1,097,265,000 | USD | 0000906709-21-000005 |
| FY 2018Yearly · 2018-12-31 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 33,308,000 | USD | 0000906709-21-000005 |
| FY 2018Yearly · 2018-12-31 | Product | Product | 20,774,000 | USD | 0000906709-21-000005 |
| FY 2018Yearly · 2018-12-31 | Product | Royalty | 41,976,000 | USD | 0000906709-21-000005 |
| FY 2017Yearly · 2017-12-31 | Product | License Collaboration And Other Revenue | 210,965,000 | USD | 0000906709-20-000004 |
| FY 2017Yearly · 2017-12-31 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 30,531,000 | USD | 0000906709-20-000004 |
| FY 2017Yearly · 2017-12-31 | Product | Product | 32,688,000 | USD | 0000906709-20-000004 |
| FY 2017Yearly · 2017-12-31 | Product | Royalty | 33,527,000 | USD | 0000906709-20-000004 |
| FY 2016Yearly · 2016-12-31 | Product | License Collaboration And Other Revenue | 60,382,000 | USD | 0001564590-19-005639 |
| FY 2016Yearly · 2016-12-31 | Product | Non Cash Royalty Revenue Related To Sale Of Future Royalties | 30,158,000 | USD | 0001564590-19-005639 |
| FY 2016Yearly · 2016-12-31 | Product | Product | 55,354,000 | USD | 0001564590-19-005639 |
| FY 2016Yearly · 2016-12-31 | Product | Royalty | 19,542,000 | USD | 0001564590-19-005639 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.